These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8772742

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease.
    Setoguchi S, Mohri M, Shimokawa H, Takeshita A.
    J Am Coll Cardiol; 2001 Aug; 38(2):493-8. PubMed ID: 11499743
    [Abstract] [Full Text] [Related]

  • 24. Aging-associated endothelial dysfunction in humans is reversed by L-arginine.
    Chauhan A, More RS, Mullins PA, Taylor G, Petch C, Schofield PM.
    J Am Coll Cardiol; 1996 Dec; 28(7):1796-804. PubMed ID: 8962569
    [Abstract] [Full Text] [Related]

  • 25. Endothelial dysfunction in patients with chest pain and normal coronary arteries.
    Quyyumi AA, Cannon RO, Panza JA, Diodati JG, Epstein SE.
    Circulation; 1992 Dec; 86(6):1864-71. PubMed ID: 1451258
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
    Brugaletta S, Heo JH, Garcia-Garcia HM, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Smits PC, Koolen J, McClean D, Dorange C, Veldhof S, Rapoza R, Onuma Y, Bruining N, Ormiston JA, Serruys PW.
    Eur Heart J; 2012 Jun; 33(11):1325-33. PubMed ID: 22507972
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension.
    Houghton JL, Davison CA, Kuhner PA, Torossov MT, Strogatz DS, Carr AA.
    J Am Coll Cardiol; 1998 Feb; 31(2):374-82. PubMed ID: 9462582
    [Abstract] [Full Text] [Related]

  • 36. Transient impairment of vasomotion function after successful chronic total occlusion recanalization.
    Galassi AR, Tomasello SD, Crea F, Costanzo L, Campisano MB, Marzá F, Tamburino C.
    J Am Coll Cardiol; 2012 Feb 21; 59(8):711-8. PubMed ID: 22340262
    [Abstract] [Full Text] [Related]

  • 37. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease.
    Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Matsui T, Ohsuzu F, Ishihara M, Kurita A.
    Circ J; 2006 Jan 21; 70(1):49-56. PubMed ID: 16377924
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. N-acetylcysteine improves coronary and peripheral vascular function.
    Andrews NP, Prasad A, Quyyumi AA.
    J Am Coll Cardiol; 2001 Jan 21; 37(1):117-23. PubMed ID: 11153725
    [Abstract] [Full Text] [Related]

  • 40. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
    Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P.
    Circulation; 1990 Feb 21; 81(2):491-7. PubMed ID: 2105174
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.